NasdaqGM - Delayed Quote USD
Oruka Therapeutics, Inc. (ORKA)
At close: November 1 at 4:00 PM EDT
After hours: November 1 at 4:00 PM EDT
Key Executives
Key Executives Information Not Available
Oruka Therapeutics, Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Oruka Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
January 30, 2025 at 9:00 PM UTC - February 3, 2025 at 9:00 PM UTC
Oruka Therapeutics, Inc. Earnings Date
Recent Events
August 28, 2024 at 12:00 AM UTC
Dividend Date
Related Tickers
SYRE Spyre Therapeutics, Inc.
33.98
+4.46%
APGE Apogee Therapeutics, Inc.
54.49
+4.71%
DNTH Dianthus Therapeutics, Inc.
28.01
+0.54%
MBX MBX Biosciences, Inc.
22.46
-1.92%
IRON Disc Medicine, Inc.
47.13
+5.15%
MLTX MoonLake Immunotherapeutics
46.76
+0.73%
KROS Keros Therapeutics, Inc.
59.94
+3.27%
OKUR OnKure Therapeutics, Inc.
16.29
-6.91%
VRDN Viridian Therapeutics, Inc.
22.28
+3.29%
ATXS Astria Therapeutics, Inc.
11.32
+1.25%